Literature DB >> 1545159

Effects of antineoplastic agents and hyperthermia on cytotoxicity toward chronically hypoxic glioma cells.

M Watanabe1, R Tanaka, H Hondo, M Kuroki.   

Abstract

The effects of hyperthermia and antineoplastic agents on the cytotoxicity to normally oxygenated and chronically hypoxic glioma cells were investigated in vitro. Exposure to temperatures above 43.0 degrees C was less cytotoxic to hypoxic cells which predominantly accumulated in the G0/G1 phase fraction. On the other hand, mitomycin C (MMC) and adriamycin (ADM) were preferentially cytotoxic to hypoxic cells not only at 37 degrees C but also at elevated temperatures (42 degrees C and 43 degrees C). These two agents showed marked synergistic effects with hyperthermia under both oxygenated and hypoxic conditions. In contrast, bleomycin (BLM), cis-diamminedichloroplatinum(II) (CDDP), and vincristine (VCR) were preferentially cytotoxic to oxygenated cells at both 37 degrees C and elevated temperatures. CDDP showed cytotoxic synergism with hyperthermia that appeared to be oxygen-dependent. A nitrosourea derivative, 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU), showed no major preferential toxicity under either oxygenated or hypoxic conditions. This study suggests that hyperthermia in combination with MMC or ADM would have a greater cytotoxic effect on hypoxic cell subpopulations of malignant gliomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1545159     DOI: 10.3109/02656739209052885

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  5 in total

1.  Thermal Therapy Approaches for Treatment of Brain Tumors in Animals and Humans.

Authors:  A L Bredlau; M A McCrackin; Anjan Motamarry; Kris Helke; Chao Chen; Ann-Marie Broome; Dieter Haemmerich
Journal:  Crit Rev Biomed Eng       Date:  2016

Review 2.  Hyperthermia treatment advances for brain tumors.

Authors:  Georgios P Skandalakis; Daniel R Rivera; Caroline D Rizea; Alexandros Bouras; Joe Gerald Jesu Raj; Dominique Bozec; Constantinos G Hadjipanayis
Journal:  Int J Hyperthermia       Date:  2020-07       Impact factor: 3.914

3.  Transcranial electro-hyperthermia combined with alkylating chemotherapy in patients with relapsed high-grade gliomas: phase I clinical results.

Authors:  Caecilia Wismeth; Christine Dudel; Christina Pascher; Paul Ramm; Torsten Pietsch; Birgit Hirschmann; Christiane Reinert; Martin Proescholdt; Petra Rümmele; Gerhard Schuierer; Ulrich Bogdahn; Peter Hau
Journal:  J Neurooncol       Date:  2009-12-24       Impact factor: 4.130

Review 4.  Advances in local therapy for glioblastoma - taking the fight to the tumour.

Authors:  Thomas S van Solinge; Lisa Nieland; E Antonio Chiocca; Marike L D Broekman
Journal:  Nat Rev Neurol       Date:  2022-03-11       Impact factor: 44.711

5.  Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei.

Authors:  Rei Noguchi; Yuki Yoshimatsu; Yooksil Sin; Takuya Ono; Ryuto Tsuchiya; Hiroshi Yoshida; Tohru Kiyono; Yutaka Yonemura; Tadashi Kondo
Journal:  J Pers Med       Date:  2022-02-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.